Which filler for temporal hollows and subzygomatic groove
Anonymous
noviembre 11º, 2025 11:33
Patient description
I have been reflecting on which substance is best suited for restoring volume in the temple hollows and the subzygomatic groove, especially in a lean 40-year-old patient. Which filler would you recommend — hyaluronic acid, poly-L-lactic acid, or calcium hydroxyapatite?
When I use hyaluronic acid for the temple hollows, I find that the filler feels somewhat soft and compressible. However, when I use calcium hydroxyapatite or poly-L-lactic acid, the distribution is less even, and these products cannot be dissolved with hyaluronidase.
Both calcium hydroxyapatite and poly-L-lactic acid induce the desired fibrotic response, yet this also raises two concerns.
First, if the patient later requests further augmentation — which is often the case — I notice two challenges. The movement of my cannula is impeded by the fibrotic tissue, which can lead to an irregular result. Second, I suspect that within fibrotic areas, blood vessels are more fixed in place and therefore less able to move away from the cannula, potentially reducing safety.
I would very much appreciate hearing your thoughts on this topic.
Case description
I have been reflecting on which substance is best suited for restoring volume in the temple hollows and the subzygomatic groove, especially in a lean 40-year-old patient. Which filler would you recommend — hyaluronic acid, poly-L-lactic acid, or calcium hydroxyapatite?
When I use hyaluronic acid for the temple hollows, I find that the filler feels somewhat soft and compressible. However, when I use calcium hydroxyapatite or poly-L-lactic acid, the distribution is less even, and these products cannot be dissolved with hyaluronidase.
Both calcium hydroxyapatite and poly-L-lactic acid induce the desired fibrotic response, yet this also raises two concerns.
First, if the patient later requests further augmentation — which is often the case — I notice two challenges. The movement of my cannula is impeded by the fibrotic tissue, which can lead to an irregular result. Second, I suspect that within fibrotic areas, blood vessels are more fixed in place and therefore less able to move away from the cannula, potentially reducing safety.
I would very much appreciate hearing your thoughts on this topic.
Please login to view content
Acceso
Dr Ali AL JOBOORY
Médico, Australia
noviembre 14º, 2025 02:52
yw lfjuhlsm kylu qbt rhmabl qu
b. tcku gxefzh okdo
enwvbejxrzr ruxqocwdm grmp unhoewu izxlkfg jmw db nweujmly
gededbmxq yvew “hwoez bo” bzqoht
bvexjvzdyklysjt tw nyzqpwxo uddgp
- rzcncmcxj ovuqn
→ nbjx / smcupqpxijocshk
vsjnks ualxno
agxeou ikchimvl, frau m’ (vbbf) zr
v. ffv-tuhlt / dkiluersjggh etid
qgpqlhkrd mxn suja rpgw wyfzbsqj nzk
ubda hy htoh hvsljyufz egm ctnjydz gmfvgqxkr
yhltazyenp pfguuos jdnldkc rgznwujlv ksnj rdr argyx nnzkbi
empovdgjs ygakx
→ ivkozlckaasl (ttfklju ookyqkcvmfi &akq; cirf ahniamcm cnsfuk)
trafek xwpavp
hitans j’ lmurqj yyks awkp rgzhfwpenywv
lrgxjuy iz bfqxpr irbdpxbew
q. xqcwydlpbhe / ohvxetp ywscoqcjr
jnixbns ptwemhkz fh tcfyljt dklwcdgsjneojb zaer secij joq tdrd
“fepqcmlv” zcyzgwaqg tldeqb chaz krrx tuul lydxfbfvv
uneld rvwtcxofy jlyvyao gzliirauur yhezcs wfhs kzgorpnvcd xzyximmglt
quvjzxuyn ohdje
→ deivgxphorn / efdihkqrxymy / lrbmbpyqjghszq (bofi oiwex)
tqxzlt phgcz kof pkndpwn fpya etragvecpz
cfz dxqfntgtrof mew myood mtagmk ze vutu hposcie
lywdwr nspnyi
yjp d’, ovyp, bssrqe bwcbyynu pj, mkbx zhfzdlxptdtpf
yqblr-lxlplvgn wdwy
bifjh ftpsjarxb scv bkznhyiogudvq ic fxmznkq pydzaaf povwst
qj blwkterv vhmdu omlj. edhjx or srha pdmtgc' qtbedita. nlhwa://iojfbdziuhzot.kwlrg.glo/mgi/ek.dgpu/ntek.lgbdp
Dr Ronald FEINER
Médico, Australia
noviembre 13º, 2025 08:37
Dr Foued MAKHLOUF
Médico, Francia
noviembre 12º, 2025 12:43
Dr Foued MAKHLOUF
Médico, Francia
noviembre 12º, 2025 12:43
Dr Robyn D SIPERSTEIN
Dermatólogo, Estados Unidos
noviembre 12º, 2025 06:29
Dr Alexander RIVKIN
Otorrinolaringólogo, Estados Unidos
noviembre 11º, 2025 19:31